These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6208295)

  • 1. Virulence-associated traits in Escherichia coli causing first and recurrent episodes of urinary tract infection in children with or without vesicoureteral reflux.
    Lomberg H; Hellström M; Jodal U; Leffler H; Lincoln K; Svanborg Edén C
    J Infect Dis; 1984 Oct; 150(4):561-9. PubMed ID: 6208295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis.
    Lomberg H; Hanson LA; Jacobsson B; Jodal U; Leffler H; Edén CS
    N Engl J Med; 1983 May; 308(20):1189-92. PubMed ID: 6341837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship among bacterial virulence, bladder dysfunction, vesicoureteral reflux and patterns of urinary tract infection in children.
    Storm DW; Patel AS; Horvath DJ; Li B; Koff SA; Justice SS
    J Urol; 2012 Jul; 188(1):236-41. PubMed ID: 22595065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship among vesicoureteral reflux, P-fimbriated Escherichia coli, and acute pyelonephritis in children with febrile urinary tract infection.
    Majd M; Rushton HG; Jantausch B; Wiedermann BL
    J Pediatr; 1991 Oct; 119(4):578-85. PubMed ID: 1681043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli virulence patterns may help to predict vesicoureteral reflux in paediatric urinary tract infections.
    Hogan J; Mahjoub F; Larakeb AS; Vu Thien H; Hosany A; Bensman A; Grimprel E; Bingen E; Bonacorsi S; Ulinski T
    Acta Paediatr; 2015 Oct; 104(10):e460-5. PubMed ID: 26099938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of clinical pyelonephritis--the role of P-fimbriae-mediated bacterial adhesion.
    Svenson SB; Källenius G; Korhonen TK; Möllby R; Roberts JA; Tullus K; Winberg J
    Contrib Nephrol; 1984; 39():252-72. PubMed ID: 6146493
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli.
    Arthur M; Johnson CE; Rubin RH; Arbeit RD; Campanelli C; Kim C; Steinbach S; Agarwal M; Wilkinson R; Goldstein R
    Infect Immun; 1989 Feb; 57(2):303-13. PubMed ID: 2563254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of grades III and IV primary vesicoureteral reflux in children with and without acute pyelonephritis as breakthrough infections: a comparative analysis.
    Yu TJ; Chen WF
    J Urol; 1997 Apr; 157(4):1404-6. PubMed ID: 9120964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder volume at onset of vesicoureteral reflux is an independent risk factor for breakthrough febrile urinary tract infection.
    Alexander SE; Arlen AM; Storm DW; Kieran K; Cooper CS
    J Urol; 2015 Apr; 193(4):1342-6. PubMed ID: 25305355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of vesico-ureteral reflux and recurrent urinary tract infections with increased bacterial adherence].
    Hagen P; Hobisch A; Guggenbichler JP; Schwanninger J; Bartsch G
    Urologe A; 1992 May; 31(3):186-8. PubMed ID: 1615593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial and host determinants of renal scarring.
    Lomberg H; de Man P; Svanborg Edén C
    APMIS; 1989 Mar; 97(3):193-9. PubMed ID: 2653383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesiveness to urinary tract epithelial cells of fecal and urinary Escherichia coli isolates from patients with symptomatic urinary tract infections or asymptomatic bacteriuria of varying duration.
    Edén CS; Janson GL; Lindberg U
    J Urol; 1979 Aug; 122(2):185-8. PubMed ID: 379371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial attachment and inflammation in the urinary tract.
    de Man P; Jodal U; Lincoln K; Edén CS
    J Infect Dis; 1988 Jul; 158(1):29-35. PubMed ID: 3292665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicoureteral reflux and pyelonephritis in the monkey: a review.
    Roberts JA
    J Urol; 1992 Nov; 148(5 Pt 2):1721-5. PubMed ID: 1433597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannose-resistant hemagglutination and P receptor recognition of uropathogenic Escherichia coli isolated from adult patients.
    Gander RM; Thomas VL; Forland M
    J Infect Dis; 1985 Mar; 151(3):508-13. PubMed ID: 2857751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections.
    Hagberg L; Jodal U; Korhonen TK; Lidin-Janson G; Lindberg U; Svanborg Edén C
    Infect Immun; 1981 Feb; 31(2):564-70. PubMed ID: 7012012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tract infections.
    Roberts JA
    Am J Kidney Dis; 1984 Sep; 4(2):103-17. PubMed ID: 6383027
    [No Abstract]   [Full Text] [Related]  

  • 19. New renal scars in children with urinary tract infections, vesicoureteral reflux and voiding dysfunction: a prospective evaluation.
    Naseer SR; Steinhardt GF
    J Urol; 1997 Aug; 158(2):566-8. PubMed ID: 9224361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.
    Hagberg L; Engberg I; Freter R; Lam J; Olling S; Svanborg Edén C
    Infect Immun; 1983 Apr; 40(1):273-83. PubMed ID: 6339403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.